Reappraisal of [18F]FDG-PET/CT for diagnosis and management of cardiac implantable electronic device infections. Posted on January 9th, 2024 by LEADconnection Post navigation Previous: Transvenous lead extraction safety and efficacy in infected and non-infected patients using mechanical-only tools, prospective registry from a high-volume center.Next: Novel Hematological Parameters in the Assessment of the Extent of Cardiac Implantable Electronic Device-Related Infections.
Transvenous lead extraction safety and efficacy in infected and non-infected patients using mechanical-only tools, prospective registry from a high-volume center. Posted on January 9th, 2024 by LEADconnection Post navigation Previous: Do barrier dressings reduce cardiac implantable device infection: Protocol for a randomized controlled trial (BARRIER-PROTECT).Next: Reappraisal of [18F]FDG-PET/CT for diagnosis and management of cardiac implantable electronic device infections.
Do barrier dressings reduce cardiac implantable device infection: Protocol for a randomized controlled trial (BARRIER-PROTECT). Posted on January 9th, 2024 by LEADconnection Post navigation Previous: Leadless Pacemaker Infection Risk in Patients with Cardiac Implantable Electronic Device Infections: A Case Series and Literature Review.Next: Transvenous lead extraction safety and efficacy in infected and non-infected patients using mechanical-only tools, prospective registry from a high-volume center.
